Forecast Period
|
2024-2028
|
Market Size (2022)
|
USD 993.05 Million
|
CAGR (2023-2028)
|
6.75%
|
Fastest Growing Segment
|
ICSI In-Vitro Fertilization
|
Largest Market
|
Saudi Arabia
|
Market Overview
The GCC In-Vitro
Fertilization Market was valued at USD 993.05 Million in 2022 and is
anticipated to project robust growth in the forecast period with a CAGR of 6.75%
through 2028. The In Vitro Fertilization (In-Vitro Fertilization) market in the
Gulf Cooperation Council (GCC) region is experiencing significant growth and
transformation, reflecting evolving societal trends and advances in
reproductive medicine. GCC countries, including Saudi Arabia, the United Arab
Emirates, Qatar, Oman, Bahrain, and Kuwait, have witnessed a notable rise in
infertility rates, attributed to factors such as delayed childbearing,
lifestyle changes, and increased awareness of fertility treatments. The GCC In-Vitro
Fertilization market is characterized by an increasing demand for assisted
reproductive technologies (ART), with a particular focus on In-Vitro
Fertilization procedures. This surge can be attributed to changing family
dynamics, where couples are often opting for smaller families and postponing
parenthood.
Furthermore, the region's
healthcare infrastructure has seen substantial improvements, with a growing
number of specialized fertility clinics and centers offering cutting-edge In-Vitro
Fertilization treatments and services. Governments in the GCC have also
recognized the importance of reproductive health, leading to favorable policies
and regulations that support and regulate the In-Vitro Fertilization industry. Rapid
advancements in In-Vitro Fertilization technology, including preimplantation
genetic testing (PGT) and in vitro maturation (IVM), have bolstered the success
rates of fertility treatments in the GCC. The market also benefits from
increasing medical tourism, with individuals from neighboring regions seeking
high-quality and accessible In-Vitro Fertilization services in the GCC. In
conclusion, the GCC In-Vitro Fertilization market is poised for continued
expansion, driven by changing demographics, improved healthcare infrastructure,
favorable regulatory environments, and ongoing advancements in reproductive
medicine. This sector is expected to play a pivotal role in addressing
infertility-related challenges in the region.
Key Market Drivers
Rising Prevalence of
Infertility is Thriving the GCC In-Vitro Fertilization Market
Infertility is highly prevalent
today. According to Research gate, in the GCC countries, clinical fertility and
the demographic fertility report as 17.2% and 38.5%, respectively. Infertility
can be caused by many factors, including lifestyle changes, stress, hormonal
imbalances, medical conditions, and aging. In GCC countries, changes in social
conditions such as late marriage, work-oriented lifestyles, and urbanization
are leading to an increase in infertility. The main symptom of infertility is
the inability to conceive and about one-third of the infertility rises from
female factors. In the remaining cases, the cause is either unknown or a
combination of male and female infertility issues.
Factors such as rising
obesity rates, sexually transmitted infections (STIs), and environmental
pollution have also led to an increase in fertility problems in GCC countries.
As per the National Library of Medicine, the prevalence of obesity among female
children and adolescents in Gulf Countries ranged from3% to 18% in 2020.
There are a number of factors
which contribute to the growth of the GCC in-vitro fertilization market.
Firstly, the increasing prevalence of infertility has led to a higher demand
for In-Vitro Fertilization treatments. Couples who are unable to conceive
naturally are turning to In-Vitro Fertilization as a viable option to fulfill
their desire to have a child. Additionally, advances in reproductive technology
and increasing success rates of In-Vitro Fertilization have increased the
confidence of couples seeking fertility treatments, further increasing the
demand for In-Vitro Fertilization services in the GCC countries.
Secondly, the growing
awareness and acceptance of infertility as a medical condition in the GCC have
led to more couples seeking professional help. Earlier, infertility was often
stigmatized or kept hidden due to cultural or societal reasons. However, with
changing mindsets and increasing awareness about infertility and its
treatments, more couples are coming forward to seek fertility treatments,
including In-Vitro Fertilization, leading to increased adoption among people
with infertility conditions.
According to research carried
out by ART Fertility Clinics, infertility rates in GCC states in 2020 were as
high as 35 to 40 percent. Furthermore, the prevalence of polycystic ovary
syndrome among women in the GCC countries is contributing to the growth of the
market. As per the National Library of Medicine, at least 20%-25% of women in
the Gulf region suffer from PCOS.
Rising Awareness and Literacy
Rate in the GCC Region
One of the main drivers of
the increased demand for In-Vitro Fertilization is the growing awareness of
infertility and available treatment options. Changes in social norms and
increased access to information via the internet and social media have led
couples to more openly discuss fertility issues and seek help from fertility clinics.
Moreover, the GCC has a strong culture of health promotion and many GCC
organizations and NGOs are actively working to raise awareness in the field of
infertility and pregnancy. Furthermore, celebrities and public figures openly
sharing their In-Vitro Fertilization success stories have played a significant
role in raising awareness and reducing the stigma associated with infertility.
For ensuring the safety and
ethical practice of In-Vitro Fertilization, legal frameworks have also been
developed by governments. These regulations assure that fertility centers
adhere to comprehensive quality standards, protect patients' privacy and comply
with proper procedures for processing and storage of embryos. It also
contributed to the growing need for In-Vitro Fertilization, by building trust
between couples that sought services in this area. For instance, Dubai
Fertility Centre was established in collaboration between Dubai Health
Authority and London Fertility Centre. The Centre provides a comprehensive and
Innovative range of infertility treatments solutions for couples who live in
the United Arab Emirates, and visiting couples in the other countries,
especially GCC. The center's objectives is to provide specialized fertility
services within the Gulf region. Furthermore, the new In-Vitro Fertilization
law was announced by the President of the United Arab Emirates, which allowed
the fertility centers to freeze unfertilized eggs, sperms, and human embryos,
thereby driving the growth of the GCC in-vitro fertilization market.
As per the National Library
of Medicine, there is a direct relationship between the literacy and
infertility rate, which show that the prevalence of infertility decreases
significantly with the rising literacy rates in the GCC region. Moreover, it
was found that high literacy rates were associated with a higher rate of infant
survival. As per the United Nations Population Fund, Oman has the highest
literacy rate of 93.3% in the GCC followed by Kuwait, that is 86.5%.
Women in resource-poor,
predominantly immigrant communities seeking fertility treatment have greater
knowledge gaps in fertility and lower levels of health literacy than women in
well-resourced clinical settings. Hence, rising literacy levels especially
among the women in GCC are expected to spur the growth of the GCC in-vitro
fertilization market during the forecast period.
Rising Reproductive Tourism
The number of medical
tourists travelling to the United Arab Emirates for fertility treatment,
especially In-Vitro Fertilization, is increasing. Medical tourists from all
over the Gulf Cooperation Council, East and North Africa, the Indian
subcontinent, and Asia prefer to travel to the United Arab Emirates for world
class healthcare, ease of access and competitive affordability offered by the
country, which is spurring the growth of the GCC in-vitro fertilization market.
To promote and develop the
domestic medical tourism market, infertility centers in the GCC provides Skype
consultations for patients, coordinates the stimulation process in their home
countries, and also arranges medical visas, hotel accommodation and
transportation, which augments the growth of the market. As per the Dubai
Health Authority, medical tourist spending in Dubai was reported to be 198.75
million USD in 2021. In 2021, Dubai received 630,000 tourists from abroad for
healthcare. In 2021, the top three regions for fertility treatment in Dubai
were Asia (34%), Africa (24%), and Europe (19%).
As per the Medical Tourism
Association (MTA), Abu Dhabi has been placed 8th out of 46 destinations in 2020
to 2021 health tourism rankings and 9th for quality of facilities and services.
Several factors are responsible for increasing reproductive medical tourism in
GCC. These include, high quality medical treatment, strict safety measures and
regulatory, advanced medical technologies, easy accommodation, and the well
certified and professional healthcare team, which attracts a large number of
tourist around the globe for infertility treatment.
The Government of the United
Arab Emirates launched Medical tourism portals (Abu Dhabi Medical Tourism
portal, Dubai Health Experience) to allow international tourist to book
appointment for various procedures, as well as access to a wide range of
tourism services. Services range from direct contact with healthcare providers,
visa issuance, reservation of accommodation and transport for travel to other
recreational activities.
In addition, GCC countries
are excellent destination for relaxing and recuperating from medical procedures
due to the heat and humidity of their climate, which is responsible for
attracting reproductive tourism, thereby driving the growth of the GCC in-vitro
fertilization market.
Download Free
Sample Report
Key Market Challenges
Lack of Skilled Professionals
The success of In-Vitro
Fertilization treatment heavily relies on the expertise of skilled
professionals and the availability of state-of-the-art infrastructure. The GCC
countries face a shortage of skilled fertility specialists, embryologists, and
nurses specialized in reproductive medicines. Inadequate training programs and
limited professional development opportunities contribute to the scarcity of
experienced professionals in the field. Additionally, the lack of well-equipped
fertility clinics and laboratories poses challenges to the delivery of
high-quality In-Vitro Fertilization services.
Unskilled healthcare
professionals reduces the success rate of the treatment and are further
deteriorating the fertility of people, which may hamper the growth of the
market during the forecast period.
Risks and Side Effects
In-Vitro Fertilization
treatment increases the risks of congenital abnormalities in babies born
through In-Vitro Fertilization. Also, embryonic arrest substantially reduces
the success rate of the treatment. Also, eggs quality and quantity are
decreasing with the age of women. In-Vitro Fertilization also increases the
probability of premature birth. As women age, it is well known that their
chances of pregnancy decrease, which results in the discontinuation of the
treatment.
Also, the serious side
effects associated with the in-vitro fertilization ovarian hyperstimulation
syndrome (OHSS), allergic reactions, hot flashes, bruising and soreness, nausea
and vomiting, weight gain, and abnormal spotting are hampering couples from
undergoing the In-Vitro Fertilization treatment, which may hamper the growth of
GCC in-vitro fertilization market during the forecast period.
High Cost
The high cost of In-Vitro Fertilization
treatment acts as a barrier for many couples who may not have the financial
means to pursue fertility treatments.
Also, the cost for every
couple vary, depending upon the various health conditions, requirements and the
number of In-Vitro Fertilization cycles opted by the patient, which adversely
impacts the market growth. In-Vitro Fertilization procedures can be expensive,
including costs associated with medications, laboratory procedures, and
consultations. Additional ultrasounds and scans, further increase the overall
cost of the treatment.
Limited insurance coverage
for In-Vitro Fertilization procedures adds to the financial burden, making it
difficult for a broader segment of the population to access In-Vitro
Fertilization services. Such factors may hamper the growth of the market in the
coming years.
Key Market Trends
Increasing Insurance Coverage
The GCC in-vitro
fertilization market is expanding as many insurance companies in the GCC are
expanding coverage for infertility treatments, including In-Vitro Fertilization.
This is making these treatments more accessible and affordable for a larger
segment of the population, thereby driving market growth. For instance,
comprehensive health insurance policies, including coverage for In-Vitro
Fertilization treatments and conditions, can be provided by CCW global to the
United Arab Emirates, which fill further propel the growth of the market during
the projected period
Improving Testing Techniques
Diagnostic techniques are an
important integral part of the In-Vitro Fertilization process. The continuously
evolving testing techniques have eventually led to the increasing pregnancy
rates among the women. The development of new genetic test is prompting the
demand for In-Vitro Fertilization treatment. The tests are now allowing embryos
to be evaluated more deeply and for the detection of disease. For the purpose
of detecting abnormalities, specific diseases and for the purpose of general
screening, which can contribute to the growth of the GCC in-vitro fertilization
market during the forecast period. If the cost is affordable, genetic testing
will be carried out on all embryos. The ultimate goal of In-Vitro Fertilization
continues to be the detection of the best embryo, but while this is improving,
there is still a lack of a clinically relevant breakthrough in this area.
Training and Infrastructure
Development
Investing in training
programs for healthcare professionals specializing in reproductive medicine is
crucial. Additionally, improving the infrastructure and resources available in
fertility clinics and laboratories can enhance the quality and accessibility of
In-Vitro Fertilization services. Also, with the increasing certified healthcare
professionals the success rate of the treatment will also increase, which will
further attract more patients for undergoing In-Vitro Fertilization. There is
also a growing emphasis on quality and accreditation in market. Clinics and
fertility centers are focusing on obtaining internationally recognized
accreditations and certifications to ensure patient safety, adhere to ethical
standards, and enhance trust among prospective patients.
Advances in Technology and
Rising Innovations
Innovations associated with
fertility treatment helps in the improvement of the health and wellbeing of the
baby through genetic screening and testing. These innovations are also
beneficial to reducing the risk of certain types of genetic disease, in addition
to addressing fertility problems. Automatization of the In-Vitro Fertilization
laboratory will give rise to another stage in In-Vitro Fertilization that is
more accessible. It will be more reproducible, with a smaller variation in the
centers. The emergence of innovative technologies is the latest development in
embryo culture medium such as embryonic genetic testing, detection of genetic
diseases before the transfer of embryos, and oocyte preservation, which are
already creating standard shifts in the field of assisted reproduction
technology.
Favorable Laws and Regulatory
Governments and healthcare
providers should explore options to reduce the financial burden of In-Vitro
Fertilization treatment. This can include insurance coverage for fertility treatments
or the establishment of financial assistance programs. Also, the new In-Vitro
Fertilization law provides framework for intragovernmental consultation and
decision making in the field of fertility treatment, which will allow
increasing research into the area of the fertility treatments. Harmonizing In-Vitro
Fertilization regulations across GCC countries can reduce inconsistencies and
provide a clear legal framework for In-Vitro Fertilization practices. Regular
review and updating of regulations can ensure they keep pace with advancements
in reproductive technologies.
Segmental Insights
Technique Insights
Based on the technique, ICSI
(Intracytoplasmic Sperm Injection) In-Vitro Fertilization has emerged as the
dominant choice in the GCC In-Vitro Fertilization market for several compelling
reasons. First and foremost, ICSI is highly effective in addressing male
infertility issues, which are prevalent in the region. Lifestyle factors, such
as high rates of obesity and tobacco use, have contributed to male fertility
problems, making ICSI a preferred method for overcoming these challenges by
directly injecting a single sperm into an egg, bypassing natural barriers.
Furthermore, ICSI is known for its high
success rates, making it a preferred choice for couples seeking fertility
treatment. Its precision and ability to enhance fertilization have made it a
reliable option, especially in cases where conventional In-Vitro Fertilization
techniques may have failed. This high success rate aligns with the aspirations
of GCC couples who often seek fertility treatments with the expectation of
successful outcomes. The GCC region's commitment to advanced healthcare and
technology has also driven the popularity of ICSI In-Vitro Fertilization.
Fertility clinics and centers in the GCC offer state-of-the-art facilities and
well-trained medical professionals proficient in ICSI techniques. The growing
medical tourism industry in the region attracts patients from neighboring
countries, further promoting the dominance of ICSI In-Vitro Fertilization in
the GCC In-Vitro Fertilization market. In summary, ICSI In-Vitro Fertilization's
effectiveness in addressing male infertility, its high success rates, and the
region's advanced healthcare infrastructure collectively contribute to its
dominant position in the GCC In-Vitro Fertilization market, meeting the growing
demand for effective fertility treatments in the region.
Reagent Insights
Based on the reagent, Embryo culture
media holds a dominant position in the GCC In-Vitro Fertilization (In Vitro
Fertilization) market due to its pivotal role in ensuring the successful
development of embryos during the critical early stages of In-Vitro
Fertilization treatment. Several factors contribute to its dominance: Embryo
culture media provide a carefully controlled environment for embryos to thrive.
In the GCC, where environmental conditions can be harsh, this level of control
is crucial for maximizing the chances of successful embryo development. These
media are designed to mimic the natural conditions of the female reproductive
tract, promoting healthy embryo growth. In a region where infertility rates are
on the rise, optimizing these conditions is paramount.
The use of high-quality embryo culture
media has been linked to improved In-Vitro Fertilization success rates,
aligning with the expectations of couples seeking fertility treatments in the
GCC. GCC countries often have stringent
regulations to ensure the safety and efficacy of medical products, including
those used in In-Vitro Fertilization. The presence of reliable and approved
embryo culture media in the market meets these regulatory standards.
Fertility clinics and centers in the GCC
region have access to advanced technology and medical expertise, further
emphasizing the importance of using quality embryo culture media to achieve
optimal outcomes. In conclusion, embryo culture media's role in supporting
healthy embryo development, its ability to enhance In-Vitro Fertilization
success rates, and its alignment with regional regulations and clinical
expertise make it the dominant choice in the GCC In-Vitro Fertilization market,
offering hope and solutions to couples struggling with infertility.
Download Free
Sample Report
Country Insights
Saudi
Arabia stands out as a dominant force in the GCC In-Vitro Fertilization (In
Vitro Fertilization) market for several compelling reasons:
Saudi
Arabia reports some of the highest infertility rates in the region, attributed
to factors such as delayed childbearing and lifestyle changes. This elevated
demand for fertility treatments makes the Saudi market one of the largest and
most influential in the GCC. The country boasts a well-developed healthcare
infrastructure, featuring state-of-the-art fertility clinics and centers
equipped with advanced technology and experienced medical professionals. This
infrastructure enables the delivery of high-quality In-Vitro Fertilization
services and attracts patients from neighboring countries. Saudi Arabia has
implemented regulations and standards to ensure the safety and efficacy of In-Vitro
Fertilization treatments, promoting the use of approved and reliable
technologies and methodologies. The Saudi government has shown a commitment to
supporting healthcare initiatives, including fertility treatments. This support
encourages the growth and accessibility of In-Vitro Fertilization services
within the country.
Cultural
norms and religious beliefs in Saudi Arabia emphasize the importance of family
and parenthood, driving individuals and couples to seek fertility treatments,
including In-Vitro Fertilization, when faced with infertility issues. In
summary, Saudi Arabia's high demand for fertility treatments, well-established
healthcare infrastructure, regulatory support, government initiatives, and
cultural factors collectively position it as the dominant player in the GCC In-Vitro
Fertilization market, making it a key hub for individuals seeking solutions to
infertility challenges.
Key Market Players
- HealthPlus Fertility & Women’s Health Center
- King Faisal Specialist Hospital and Research Center (KFSH&RC)
- Thuriah Medical Center
- Fakih In-Vitro Fertilization Fertility Center
- ART Fertility Clinics
- New Hope In-Vitro Fertilization
- AlReem Medical Center
- Wara Hospital
- Royale Hayat Hospital
- Quttainah Specialized Hospital
- Feto Maternal Medical Centre
- Elite Medical Center
- Bahrain Gynecology and Infertility Center
- Al Baraka Fertility Hospital
- Janeen Fertility & Genetics Centre
- Dr. Sulaiman Al Habib Medical Group
- Dr. Samir Abbas Hospital
- Mediclinic Middle East
- Al Ahli Hospital LLC
- Al Tai Medical Center
By Technique
|
By Reagent
|
By Instruments
|
By Infertility
|
By Embryo
|
By Application
|
By End Use
|
By Country
|
ICSI In-Vitro Fertilization
Non-ICSI/Traditional In-Vitro
Fertilization
|
Embryo Culture Media
Cryopreservation Media Sperm Processing Media
Ovum Processing Media
|
Imaging Systems
Sperm Separation Systems
Ovum Aspiration Pumps
Incubators Micromanipulator Systems
Cryo-systems
Others
|
Female
Male
|
Frozen-Thawed Embryo
Fresh Embryo
|
Fertility Clinics Hospitals
Others
|
Locals Expats Medical Tourists
|
Saudi Arabia
UAE
Oman
Kuwait
Qatar
Bahrain
|
Report Scope:
In this report, the GCC In-Vitro Fertilization Market
has been segmented into the following categories, in addition to the industry
trends which have also been detailed below:
- GCC In-Vitro Fertilization Market, By Technique:
o ICSI In-Vitro Fertilization
o Non-ICSI/Traditional In-Vitro
Fertilization
- GCC In-Vitro Fertilization Market, By Reagent:
o Embryo Culture Media
o Cryopreservation Media
o Sperm Processing Media
o Ovum Processing Media
- GCC In-Vitro Fertilization Market, By Infertility:
o Female
o Male
- GCC In-Vitro Fertilization Market, By Embryo:
o Frozen-Thawed Embryo
o Fresh Embryo
- GCC In-Vitro Fertilization Market, By Applications:
o Fertility Clinics
o Hospitals
o Others
- GCC In-Vitro Fertilization Market, By End User:
o Locals
o Expats
o Medical Tourists
- GCC In-Vitro Fertilization Market,
By Country:
o Saudi Arabia
o UAE
o Oman
o Kuwait
o Qatar
o Bahrain
Competitive Landscape
Company Profiles: Detailed analysis of the major companies
present in the GCC In-Vitro Fertilization Market.
Available Customizations:
The GCC In-Vitro Fertilization Market report
with the given market data, Tech Sci Research offers customizations according
to a company's specific needs. The following customization options are
available for the report:
Company Information
- Detailed analysis and
profiling of additional market players (up to five).